Suturion has raised $2.0M to help surgeons close abdomens more safely. The Swedish medtech company, founded in 2018 by surgeon Gabriel Börner and engineer Mats O. Christensson alongside LU Holding AB, is developing a device aimed at preventing incisional hernias and wound infections after open abdominal surgery rather than repairing them later. Cradle Growth provided the funding.
The round follows a completed clinical trial in 2024, which Suturion describes as an important step toward CE and FDA approval. The company has also filed several patent applications and conducted pre-clinical research.













